11.12.2012 Views

Sabato 27 ottobre 2012 - Pacini Editore

Sabato 27 ottobre 2012 - Pacini Editore

Sabato 27 ottobre 2012 - Pacini Editore

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PoStER<br />

bination chemotherapy the prognosis appears similar to that for<br />

nodal lymphoma of comparable stage and histological type. We<br />

report two cases of ovarian lymphomas in two woman of 57 and<br />

79 year-old, which underwent bilateral hystero-annessiectomy<br />

for leiomyomas and prolapse without clinically appearance of an<br />

ovarian neoplasm.<br />

Case reports. First case. A 57 year-old woman with a familiarity<br />

for lymphomas underwent hystero-annessiectomy for uterine leyomiomas.<br />

A pre-operative ultrasonography showed three uterine<br />

leyomiomas but it didn’t report any ovarian alteration. Blood tests<br />

were normal, and the patient was in good general health. On gross<br />

examination uterus showed multiple leiomyomas, and the left<br />

ovary was normal. The right ovary was 4 cm in major diameter<br />

and showed greyish, fleshy lesion 1.2 cm in major diameter. The<br />

specimen was fixed in formalin and embedden in paraffin. Thin<br />

sections were cut and stained with Haemathoxylin/Eosin. Microscopically,<br />

the tumor was composed of cellular elements of medium-large<br />

size, monomorphic, with evident atypia, growing in a<br />

storyform pattern. The neoplastic cells add abundant cytoplasm,<br />

basophilic to the Giemsa stain and hyperchromatic nuclei with<br />

evident nucleoli, rarely multiple. The lesion was not delimited by<br />

a capsule but was well defined from the surrounding parenchyma.<br />

There were also small foci of necrosis. We performed immunohistochemical<br />

staining and found positivity for LCA and CD20<br />

and negativity for CAM 5.2; CD10, CD3, CD5, CD23, CD34 and<br />

MT1. More over the proliferative cell index has determined by<br />

Ki67, was positive in the 60% of the neoplastic cells.<br />

The final diagnosis was of primary ovarian lymphoma, large cell<br />

B phenotype (WHO 2008). Although ovarian lymphoma traditionally<br />

has been considered an aggressive tumor with a poor<br />

prognosis the patient is still alive after chemotherapy.<br />

Second case. A 79-years old woman underwent hystero-annessiectomy<br />

for IV grade uterine prolapse.<br />

The patient was in good health, except for thyroid goiter; blood<br />

tests and pelvic imaging were normal. On gross examination<br />

uterus showed an evident prolapse with ulceration of cervix mucosae,<br />

left ovary was normal. The right ovary was 2 cm in major<br />

diameter and was fully replaced by a whitish, nodular lesion<br />

with a firm and rubbery consistency. The specimen was fixed in<br />

formalin and embedden in paraffin. Thin sections were cut and<br />

stained with Haemathoxylin/Eosin. Microscopically the neoplastic<br />

population was constituted by small cells with irregular nuclei<br />

(centrocytes) with only rare large cells (centroblasts: 1-2 HPF)<br />

with one or more basophilic nucleoli and a moderate amount of<br />

cytoplasm. Scattered follicular dendritic cells were intermingled<br />

with neoplastic cells and showed large nuclei with delicate nuclear<br />

membranes and prominent nucleoli, often binucleated. The<br />

tumor cells were positive for CD20, CD10 and bcl-2 and negative<br />

for CD3, CD5 and ciclyn D1. More over the proliferative cell<br />

index has determined by Ki67, was positive in the about 30% of<br />

the neoplastic cells.<br />

The final diagnosis was of primary ovarian lymphoma, follicular<br />

type, low grade (grade1) (WHO 2008). The neoplasm had an<br />

indolent course and patient is still alive after chemoterapy.<br />

Discussion. Primary ovarian lymphoma is an uncommon disease,<br />

accounting for 0,5% non Hodgkin lymphomas and 1,5% of all<br />

ovarian tumours. Most common symptoms are a vague sense<br />

of heaviness or abdominal pain, a palpable mass and ascites.<br />

Fox et al proposed three criteria for diagnosing primary ovarian<br />

lymphoma. At the time of diagnosis, only the ovary must<br />

be involved by lymphoma; peripheral blood and bone marrow<br />

must be negative for lymphomatous cells and several months<br />

must be elapsed between the appereance of the ovarian lesion<br />

and further lymphoid masses at sites different from ovary. Treatment<br />

of primary ovarian lymphoma includes surgery followed by<br />

chemotherapy. The prognosis of primary ovarian lymphoma is<br />

poor, with survival reported which varies from 0 to 36% with an<br />

average survival time less than 3 years, similar to that for nodal<br />

389<br />

lymphoma of comparable stage and histologic type. Our two<br />

cases are peculiar because they were detected as incidental findings<br />

during the work-up of other gynecologic disease, moreover<br />

they were unilateral without clinical symptoms referred to ovarian<br />

and peritoneal localization. In conclusion, we must to keep in<br />

mind that gynaecological lymphoproliferative disorders are rare<br />

but they exist and so we must suspect it. Moreover the distinction<br />

between primary and secondary lymphomas has a clinical, therapeutic<br />

and prognostic significance.<br />

references<br />

1 Scully RE. Tumors of the ovary and mal developed gonads. In: Atlas<br />

of tumor pathology. 2nd series. Washington (DL): Armed Forces Institute<br />

of Pathology 1979, fascicle 16, pp. 117-<strong>27</strong>.<br />

2 Vang R, et al. Ovarian non-Hodgkin lymphoma: a clinicopathologic<br />

study of eight primary cases. Modern Pathol 2001;14:1093-9.<br />

3 Neuhauser TS, et al. Follicle center lymphoma involving the female<br />

genital tract: a morphologic and molecular genetic study of three<br />

cases. Am Diagn Pathol 2000;4:293-9.<br />

4 Lagoo AS, et al. Lymphoma of the female genital tract: current status.<br />

Int J of Gynecol Pathol 2006;25:1-21.<br />

5 Ozsan N, et al. Clinicopathologic and genetic characterization of follicular<br />

lymphomas presenting in the ovary reveals 2 distinct subgroups.<br />

Am J Surg Pathol 35:1691-9.<br />

6 Barzilay J, et al. Malignant lymphoma of the ovary: report of a case<br />

and review of the literature. Obstet Gynecol 1984;64:93S.<br />

Polypoid endocervical adenomyoma: case report<br />

R. Ponte1 , L. Abete1 , T. Celiento1 , P. Ceriolo1 , E. Pacella1 ,<br />

P. Calamaro1 , S. Bruno1 , P. Sala2 , E. Fulcheri1 1 University of Genoa, IRCCS San martino, IST, U.O. Anatomia Patologica<br />

DISC; 2 IRCCS San martino, IST, U.O. Ginecologia e Ostetricia<br />

Introduction. Endocervical adenomyoma is a rare neoplastic<br />

condition of the uterine cervix, one of a group of endocervical<br />

benign lesions that may histologically be confused with an aggressive<br />

cervical carcinoma, adenoma malignum. It represents<br />

the benign counterpart of atypical polypoid adenomyoma of the<br />

uterine body which mainly consists of endometrial glands (which<br />

are atypical and present squamous morules) and smooth muscle<br />

cells 1 2 . The designation endocervical adenomyoma has been<br />

used for biphasic tumors composed of irregularly shaped endocervical<br />

glands with bundles of smooth muscle cells 3 . A gross<br />

well-circumscribed appearance and intermingling of bundles of<br />

smooth muscle fibres and benign-looking glands are indicative of<br />

the diagnosis. There have been only a limited number of reported<br />

cases and therefore it is important be aware of this entity to avoid<br />

any diagnostic mistakes, especially in consideration of the differential<br />

with malignancy 4 .<br />

Materials and methods. We report a case of adenomyoma of<br />

endocervical type arising in a 47-year-old female, gravida 3, para<br />

2, Italian woman. The patient was in good health without any notable<br />

family history. She had a history of relapsing menometrorrhagia<br />

and 7 years previously she had had a fibrous peduncolated<br />

formation in expulsion from the endocervical canal removed.<br />

Simple ablation without revision of the base plant had been<br />

performed. Histological examination of the lesion showed this to<br />

be an endocervical adenomyoma. After six years of good health,<br />

the symptoms recurred in 2011. The transvaginal ultrasound<br />

(Figg. 1,2) visualized a single large mass involving deeply the<br />

cervical wall and slightly protruding on the mucosal surface. In<br />

consideration of the age of the patient conservative surgical treatment<br />

by hysteroscopy was decided. This approach permitted the<br />

removal of the polypoid component only while, in consideration<br />

of the lesions persistence within the cervix wall, hysterectomy<br />

was subsequently performed.<br />

Results. Gross description identified a polypoid tumor which<br />

measured 3x2x1,5 after hysteroscopic polypectomy. The infiltrating<br />

lesion was well-circumscribed and measured 3x2,5 cm in size

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!